{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:26:08Z","timestamp":1781180768929,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.drugalcdep.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T14:36:42Z","timestamp":1540478202000},"page":"151-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015\u20132016"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5214-4776","authenticated-orcid":false,"given":"Kate","family":"Smolina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Crabtree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6397-4385","authenticated-orcid":false,"given":"Mei","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Mill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5445-8290","authenticated-orcid":false,"given":"Christian G.","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13181-018-0659-3","article-title":"Assessment of the availability, cost, and motivations for use over time of the new psychoactive substances-benzodiazepines diclazepam, flubromazepam, and pyrazolam-in the UK","volume":"14","author":"Abouchedid","year":"2018","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0010","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0020","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S108302","article-title":"Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system","volume":"7","author":"Boscarino","year":"2016","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40621-017-0118-7","article-title":"Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis","volume":"4","author":"Brady","year":"2017","journal-title":"Inj. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0035","series-title":"Chronic Disease Dashboard Case Definitions","author":"British Columbia Centre for Disease Control","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0040","series-title":"Fentany-Detected Illicit Drug Overdose Deaths","author":"British Columbia Coroners Service","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0045","series-title":"Illicit Drug Overdose Deaths in BC, January 1, 2007 - December 31, 2016","author":"British Columbia Coroners Service","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0050","series-title":"Substance Abuse in Canada: Concurrent Disorders","author":"Canadian Centre on Substance Abuse","year":"2009"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000346787","article-title":"Non-fatal opioid overdose and major depression among street-recruited young heroin users","volume":"20","author":"Chahua","year":"2014","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0060","series-title":"Clinical Handbook of Psychotropic Drugs","author":"Clinical Handbook of Psychotropic Drugs","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0065","series-title":"Professional Standards and Guidelines \u2013 Safe Prescribing of Drugs With Potential for Misuse\/Diversion","author":"College of Physicians and Surgeons of British Columbia","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/002204260603600402","article-title":"Initiation to pharmaceutical opioids and patterns of misuse: preliminary Qualitative findings obtained by the Ohio Substance Abuse Monitoring Network","volume":"36","author":"Daniulaityte","year":"2006","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0075","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC Guideline for prescribing opioids for chronic pain--United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0080","series-title":"Statistical Bulletin 2017","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0085","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1503\/cmaj.1031416","article-title":"Determinants of overdose incidents among illicit opioid users in 5 Canadian cities","volume":"171","author":"Fischer","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ypmed.2017.11.001","article-title":"The\u2019 fentanyl epidemic\u2019 in Canada - some cautionary observations focusing on opioid-related mortality","volume":"107","author":"Fischer","year":"2018","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0095","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/MLR.0000000000000431","article-title":"Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia","volume":"53","author":"Gladstone","year":"2015","journal-title":"Canada. Med. Care"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0100","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s11606-017-4288-3","article-title":"Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy","volume":"33","author":"Glanz","year":"2018","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0105","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.9778\/cmajo.20140027","article-title":"Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: A time series analysis","volume":"2","author":"Gomes","year":"2014","journal-title":"CMAJ Open"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0115","series-title":"Provincial Health Officer Declares Public Health Emergency","author":"Government of British Columbia","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157512","article-title":"Drug toxicity deaths after release from incarceration in Ontario, 2006-2013: review of Coroner\u2019s Cases","volume":"11","author":"Groot","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","article-title":"Profiles of pregabalin and gabapentin abuse by postmortem toxicology","volume":"241","author":"H\u00e4kkinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0130","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","article-title":"Patterns of abuse among unintentional pharmaceutical overdose fatalities","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0022042615604345","article-title":"Routes into opioid analgesic misuse: emergent typologies of initiation","volume":"45","author":"Harocopos","year":"2015","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugpo.2018.02.001","article-title":"Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets","volume":"55","author":"Janjua","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11606-012-2225-z","article-title":"Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008\u20132009","volume":"28","author":"Johnson","year":"2013","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0150","article-title":"BC opioid substitution treatment system: performance measures 2014\/2015-2015\/2016","author":"Kendall","year":"2017","journal-title":"British Columbia Office of the Provincial Health Officer."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","article-title":"Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users","volume":"87","author":"Kerr","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0170","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/add.13843","article-title":"Risk to heroin users of polydrug use of pregabalin or gabapentin","volume":"112","author":"Lyndon","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060600","article-title":"Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada","volume":"8","author":"Madadi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"Every\u2019 never\u2019 I ever said came true\": transitions from opioid pills to heroin injecting","volume":"25","author":"Mars","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0185","first-page":"k2270","article-title":"Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces","volume":"361","author":"Martin","year":"2018","journal-title":"Interrupted time series analysis. BMJ"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0190","series-title":"Preventing Pharmaceutical Opioid-associated Mortality in British Columbia: a Review of Prescribed Opioid Overdose Deaths, 2009-2013","author":"McLarnon","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/0022042613497935","article-title":"Everybody\u2019s doing it: initiation to prescription drug misuse","volume":"44","author":"Mui","year":"2014","journal-title":"J. Drug Issues"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/pm\/pnx038","article-title":"Risk factors for serious prescription opioid-induced respiratory depression or overdose: comparison of commercially insured and Veterans Health Affairs populations","volume":"19","author":"Nadpara","year":"2017","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/pds.3945","article-title":"A synthesis of oral morphine equivalents (OME) for opioid utilisation studies","volume":"25","author":"Nielsen","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/ser0000099","article-title":"Development and applications of the Veterans Health Administration\u2019s Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide","volume":"14","author":"Oliva","year":"2017","journal-title":"Psychol. Serv."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0215","doi-asserted-by":"crossref","first-page":"328","DOI":"10.24095\/hpcdp.38.9.04","article-title":"Patterns of health care utilization among people who overdosed from illegal drugs: A descriptive analysis using the BC Provincial Overdose Cohort","volume":"38","author":"Otterstatter","year":"2018","journal-title":"Health Promot. Chronic Dis. Prev. Can."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0220","first-page":"h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics","volume":"350","author":"Park","year":"2015","journal-title":"Case-cohort study. BMJ"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0225","first-page":"53","article-title":"Chronic pain at ages 12 to 44","volume":"21","author":"Ramage-Morin","year":"2010","journal-title":"Health Rep."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0230","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1155\/2012\/875924","article-title":"The epidemiology of chronic pain in Canadian men and women between 1994 and 2007: results from the longitudinal component of the National Population Health Survey","volume":"17","author":"Reitsma","year":"2012","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0240","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014 United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0245","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths \u2014 united States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2011\/876306","article-title":"The prevalence of chronic pain in Canada","volume":"16","author":"Schopflocher","year":"2011","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0255","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2105\/AJPH.2017.304265","article-title":"Quantifying the epidemic of prescription opioid overdose deaths","volume":"108","author":"Seth","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0260","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1360-0443.2007.02054.x","article-title":"Unintentional drug overdose death trends in New Mexico, USA, 1990\u20132005: combinations of heroin, cocaine, prescription opioids and alcohol","volume":"103","author":"Shah","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0265","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugalcdep.2012.08.014","article-title":"Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs","volume":"128","author":"Silva","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2017.05.051","article-title":"Heroin and fentanyl overdoses in Kentucky: epidemiology and surveillance","volume":"46","author":"Slavova","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0275","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.17269\/CJPH.107.5413","article-title":"Patterns and trends in long-term opioid use for non-cancer pain in British Columbia, 2005-2012","volume":"107","author":"Smolina","year":"2016","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0280","series-title":"Undetermined Risk Factors for Fentanyl-related Overdose Death - Ohio, 2015 (EpiAid 2016-003","author":"Spies","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0285","first-page":"j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose","volume":"356","author":"Sun","year":"2017","journal-title":"Retrospective analysis. BMJ"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0290","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1136\/amiajnl-2013-001856","article-title":"Using electronic health records data to identify patients with chronic pain in a primary care setting","volume":"20","author":"Tian","year":"2013","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0295","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12911-015-0155-5","article-title":"Methods for identifying 30 chronic conditions: application to administrative data","volume":"15","author":"Tonelli","year":"2015","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0300","series-title":"FDA Drug Safety Communication: FDA Urges Caution About Withholding Opioid Addiction Medications From Patients Taking Benzodiazepines or CNS Depressants: Careful Medication Management Can Reduce Risks","author":"U.S. Food & Drug Administration","year":"2016"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009","volume":"8","author":"Unick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0310","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: trends in emergency department visits for suspected opioid overdoses - United States, July 2016-September 2017","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0315","series-title":"Definitions and General Considerations","author":"World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology","year":"2018"},{"key":"10.1016\/j.drugalcdep.2018.09.019_bib0320","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618307592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:27:24Z","timestamp":1549283244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618307592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":64,"alternative-id":["S0376871618307592"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.09.019","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015\u20132016","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}